{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:21:40Z","timestamp":1792120900411,"version":"4.4.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"abstract":"<jats:p>Neurofibromatosis type 2 (NF2)-related vestibular schwannoma (NF2-VS) is a rare genetic disorder that results in bilateral acoustic neuromas. However, the exact pathogenesis of the disease is still unclear. This study aims to use bioinformatics analyses to identify potential hub genes and therapeutic. We retrieved the mRNA expression profiles (GSE108524 and GSE141801) of NF2-VS from the database, and selected the leading 25% genes with the most variance across samples for weighted correlation network analysis. Subsequently, we conducted gene ontology term and Kyoto Encyclopedia of Genes and Genomes signaling network enrichment analyses. The STRING database was employed for protein-protein interaction (PPI) axis construction. The mRNA-miRNA modulatory network was generated via the miRTarBase database. Differentially expressed genes (DEGs) were identified via the R package \u201climma\u201d in both datasets, and hub genes were screened via intersection of common DEGs, candidate hub genes from the PPI axis, and candidate hub genes from the key module. Finally, common DEGs were uploaded onto the connectivity map database to determine drug candidates. Based on our observations, the blue module exhibited the most significant relation to NF2-VS, and it included the NF2 gene. Using enrichment analysis, we demonstrated that the blue modules were intricately linked to modulations of cell proliferation, migration, adhesion, junction, and actin skeleton. Overall, 356 common DEGs were screened in both datasets, and 33 genes carrying a degree\u2005&gt;\u200515 were chosen as candidate hub genes in the PPI axis. Subsequently, 4 genes, namely, GLUL, CAV1, MYH11, and CCND1 were recognized as real hub genes. In addition, 10 drugs with enrichment scores\u2005&lt;\u2005\u22120.7 were identified as drug candidates. Our conclusions offered a novel insight into the potential underlying mechanisms behind NF2-VS. These findings may facilitate the identification of novel therapeutic targets in the future.<\/jats:p>","DOI":"10.1097\/md.0000000000036696","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T21:14:32Z","timestamp":1702674872000},"page":"e36696","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools"],"prefix":"10.1097","volume":"102","author":[{"given":"Jiasheng","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1469-5953","authenticated-orcid":false,"given":"Yuehui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-03-4079","article-title":"Comparative pathology of nerve sheath tumors in mouse models and humans.","volume":"64","author":"Stemmer-Rachamimov","year":"2004","journal-title":"Cancer Res"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary.","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00129492-200501000-00016","article-title":"Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.","volume":"26","author":"Evans","year":"2005","journal-title":"Otol Neurotol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14737175.2018.1399795","article-title":"An update on the diagnosis and treatment of vestibular schwannoma.","volume":"18","author":"Halliday","year":"2018","journal-title":"Expert Rev Neurother"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1177\/002215549904701113","article-title":"Expression of the neurofibromatosis type 2 gene in human tissues.","volume":"47","author":"den Bakker","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2174\/092986708783955527","article-title":"Microarray gene expression profiling in meningiomas and schwannomas.","volume":"15","author":"Martinez-Glez","year":"2008","journal-title":"Curr Med Chem"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update.","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis.","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters.","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks.","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies.","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease.","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"R14-20250504","first-page":"690","article-title":"Incidence of vestibular schwannoma in Denmark, 1977\u20131995.","volume":"21","author":"Howitz","year":"2000","journal-title":"Am J Otol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12253-013-9644-y","article-title":"Merlin, the NF2 gene product.","volume":"19","author":"Pecina-Slaus","year":"2013","journal-title":"Pathol Oncol Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920310791824011","article-title":"Merlin, a \u201cmagic\u201d linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.","volume":"11","author":"Stamenkovic","year":"2010","journal-title":"Curr Protein Pept Sci"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.","volume":"101","author":"Rong","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","article-title":"Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.","volume":"140","author":"Li","year":"2010","journal-title":"Cell"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","article-title":"Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types.","volume":"10","author":"James","year":"2012","journal-title":"Mol Cancer Res"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/ijms22020712","article-title":"An integrative transcriptomic analysis of systemic juvenile idiopathic arthritis for identifying potential genetic markers and drug candidates.","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.celrep.2019.09.056","article-title":"Glutamine anabolism plays a critical role in pancreatic cancer by coupling carbon and nitrogen metabolism.","volume":"29","author":"Bott","year":"2019","journal-title":"Cell Rep"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2015.09.025","article-title":"Oncogenic Myc induces expression of glutamine synthetase through promoter demethylation.","volume":"22","author":"Bott","year":"2015","journal-title":"Cell Metab"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/ncb3389","article-title":"Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth.","volume":"18","author":"Cox","year":"2016","journal-title":"Nat Cell Biol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ncb3272","article-title":"Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.","volume":"17","author":"Tardito","year":"2015","journal-title":"Nat Cell Biol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41586-018-0466-7","article-title":"Role of glutamine synthetase in angiogenesis beyond glutamine synthesis.","volume":"561","author":"Eelen","year":"2018","journal-title":"Nature"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-cellbio-100617-062737","article-title":"Caveolae: structure, function, and relationship to disease.","volume":"34","author":"Parton","year":"2018","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1083\/jcb.108.6.2401","article-title":"Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton.","volume":"108","author":"Glenney","year":"1989","journal-title":"J Cell Biol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1074\/jbc.271.7.3863","article-title":"Phosphorylation of caveolin by Src tyrosine kinases the alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo.","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"key":"R30-20250504","first-page":"5870","article-title":"Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity.","volume":"60","author":"Bender","year":"2000","journal-title":"Cancer Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"C494","DOI":"10.1152\/ajpcell.00458.2004","article-title":"Caveolin-1 in oncogenic transformation, cancer, and metastasis.","volume":"288","author":"Williams","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10555-008-9160-9","article-title":"Caveolin-1 in tumor progression: the good, the bad and the ugly.","volume":"27","author":"Goetz","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2174\/1566524014666140128112827","article-title":"Caveolin-1 in cell migration and metastasis.","volume":"14","author":"Nunez-Wehinger","year":"2014","journal-title":"Curr Mol Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/bcr2892","article-title":"Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment.","volume":"13","author":"Sotgia","year":"2011","journal-title":"Breast Cancer Res"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.2353\/ajpath.2009.080873","article-title":"An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers.","volume":"174","author":"Witkiewicz","year":"2009","journal-title":"Am J Pathol"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajmg.1320460110","article-title":"Human smooth muscle myosin heavy chain gene mapped to chromosomal region 16q12.","volume":"46","author":"Matsuoka","year":"1993","journal-title":"Am J Med Genet"},{"key":"R37-20250504","first-page":"3012","article-title":"Bioinformatics analysis of RNA-seq data revealed critical genes in colon adenocarcinoma.","volume":"21","author":"Xi","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.7314\/APJCP.2014.15.17.7223","article-title":"Down-regulated MYH11 expression correlates with poor prognosis in stage II and III colorectal cancer.","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"15607","DOI":"10.1002\/jcp.28208","article-title":"The identification of new biomarkers for bladder cancer: a study based on TCGA and GEO datasets.","volume":"234","author":"Hu","year":"2019","journal-title":"J Cell Physiol"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/omi.2018.0048","article-title":"Drug targeting and biomarkers in head and neck cancers: insights from systems biology analyses.","volume":"22","author":"Islam","year":"2018","journal-title":"OMICS"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/pcmr.12874","article-title":"An update on the implications of cyclin D1 in melanomas.","volume":"33","author":"Gonzalez-Ruiz","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc2602","article-title":"Cell cycle, CDKs and cancer: a changing paradigm.","volume":"9","author":"Malumbres","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.","volume":"25","author":"Xiao","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41419-018-1018-7","article-title":"Proscillaridin A exerts anti-tumor effects through GSK3beta activation and alteration of microtubule dynamics in glioblastoma.","volume":"9","author":"Berges","year":"2018","journal-title":"Cell Death Dis"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/1940-6207.CAPR-10-0189","article-title":"Naftopidil, a selective alpha1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.","volume":"4","author":"Hori","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2020.01.015","article-title":"Solubilization and delivery of Ursolic-acid for modulating tumor microenvironment and regulatory T cell activities in cancer immunotherapy.","volume":"320","author":"Zhang","year":"2020","journal-title":"J Control Release"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:14:35Z","timestamp":1746321275000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":47,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036696","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}